(MedPage Today) -- Treatment of patients with refractory Cushing's syndrome using the glucocorticoid receptor antagonist mifepristone led to improvements in global clinical response, a post-hoc analysis found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment